EPISODE · May 3, 2019 · 8 MIN
Friday, May 3
from FT News Briefing
Investors flock back to a complex debt-derivatives product blamed for amplifying losses in the financial crisis, thousands of US screenwriters take on their private equity-backed agents, and the billionaire founder of drugmaker Insys is among those found guilty of bribing doctors to prescribe an addictive painkiller. Plus, the FT’s banking editor David Crow explains what is next for Barclays after activist investor Edward Bramson suffered a heavy defeat in his bid for a seat on the investment bank’s board. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
Investors flock back to a complex debt-derivatives product blamed for amplifying losses in the financial crisis, thousands of US screenwriters take on their private equity-backed agents, and the billionaire founder of drugmaker Insys is among those found guilty of bribing doctors to prescribe an addictive painkiller. Plus, the FT’s banking editor David Crow explains what is next for Barclays after activist investor Edward Bramson suffered a heavy defeat in his bid for a seat on the investment bank’s board. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Friday, May 3
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m